Our data further demonstrated that the mTOR inhibitor rapamycin attenuated bleomycin-mediated lung injury and mortality (Fig 4), which is consistent with a previous study exhibiting that mTOR inhibitors are effective for treating pulmonary fibrosis in animal models[18–20, 36]. The gene discussed is MTOR; the disease is pulmonary fibrosis.